Novavax’s 2024-2025 COVID-19 Vaccine Receives EUA for Use in the U.S.
Novavax, Inc. (Nasdaq: NVAX), a leading company in protein-based vaccines, has announced that its latest COVID-19 vaccine, the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705), ... Read More
New study suggests COVID-19 vaccines may have contributed to excess deaths in Western countries
A recent study published in BMJ Public Health has sparked controversy by suggesting that COVID-19 vaccines may have contributed to a rise in excess deaths ... Read More
AstraZeneca withdraws COVID-19 vaccine amid legal challenges and commercial decisions
In a significant development, UK-based pharmaceutical giant AstraZeneca has announced the global withdrawal of its COVID-19 vaccine, known as Covishield in India and Vaxzevria in ... Read More
Pfizer withdraws emergency use application for COVID-19 vaccine in India
US pharmaceutical giant Pfizer has withdrawn its application for emergency use authorization of its BNT162b2 COVID-19 vaccine in India. This decision comes after a series ... Read More
UAE grants emergency use authorization for Sputnik V Covid-19 vaccine
The Russian Direct Investment Fund (RDIF) has announced that the UAE Ministry of Health and Prevention (MOHAP) has granted emergency use authorization for the Sputnik ... Read More
Switzerland approves Pfizer-BioNTech Covid-19 vaccine for emergency use, marking global first
Switzerland has become the first country to grant full approval for the Pfizer-BioNTech BNT162b2 Covid-19 vaccine, making a significant move in the global race against ... Read More
UK grants emergency authorization for Pfizer and BioNTech’s BNT162b2 Covid-19 vaccine
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has granted emergency use authorization (EUA) for the BNT162b2 Covid-19 vaccine candidate, developed by Pfizer and ... Read More